Paper7601145
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
Sahl HG and 2 others. Eur J Biochem, 1995. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Papers, record 7601145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7601145
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Protein Processing, Post-Translational | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Drug Design | |
| Humans | |
| Molecular Sequence Data | |
| Protein Conformation | |
| Protein Sorting Signals | |
| Structure-Activity Relationship | |
| Transcription, Genetic |
Source PubMed
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41724961 | A comparative framework of natural nisin variants: linking genetic basis to future bioengineering applications. | Microb Cell Fact | 2026 | https://conductscience.org/library/papers/41724961 | PubMed |
| 40901006 | Antimicrobial Peptides: Mechanisms, Applications, and Therapeutic Potential. | Infect Drug Resist | 2025 | https://conductscience.org/library/papers/40901006 | PubMed |
| 39311922 | Antibacterial and antibiofilm activities of bacteriocin produced by a new strain of Enterococcus faecalis BDR22. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39311922 | PubMed |
| 39203413 | Role of Carbon, Nitrogen, Phosphate and Sulfur Metabolism in Secondary Metabolism Precursor Supply in Streptomyces spp. | Microorganisms | 2024 | https://conductscience.org/library/papers/39203413 | PubMed |
| 38004689 | Plant-Associated Representatives of the Bacillus cereus Group Are a Rich Source of Antimicrobial Compounds. | Microorganisms | 2023 | https://conductscience.org/library/papers/38004689 | PubMed |
| 37507160 | Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope. | Adv Microb Physiol | 2023 | https://conductscience.org/library/papers/37507160 | PubMed |
| 37300874 | After a century of nisin research - where are we now? | FEMS Microbiol Rev | 2023 | https://conductscience.org/library/papers/37300874 | PubMed |
| 36225363 | Phylogenetic survey of the subtilase family and a data-mining-based search for new subtilisins from Bacillaceae. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36225363 | PubMed |
| 35498610 | Nisin/polyanion layer-by-layer films exhibiting different mechanisms in antimicrobial efficacy. | RSC Adv | 2020 | https://conductscience.org/library/papers/35498610 | PubMed |
| 35033086 | Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process. | Microb Cell Fact | 2022 | https://conductscience.org/library/papers/35033086 | PubMed |
| 34769122 | Antimicrobial Peptides: An Update on Classifications and Databases. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769122 | PubMed |
| 34680498 | Discovery, Optimization, and Clinical Application of Natural Antimicrobial Peptides. | Biomedicines | 2021 | https://conductscience.org/library/papers/34680498 | PubMed |
| 34066353 | The Inhibitory Concentration of Natural Food Preservatives May Be Biased by the Determination Methods. | Foods | 2021 | https://conductscience.org/library/papers/34066353 | PubMed |
| 31616392 | Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31616392 | PubMed |
| 30603877 | Bovicins: The Bacteriocins of Streptococci and Their Potential in Methane Mitigation. | Probiotics Antimicrob Proteins | 2019 | https://conductscience.org/library/papers/30603877 | PubMed |
| 30181456 | Synthesis, Characterization, and Antimicrobial Properties of Peptides Mimicking Copolymers of Maleic Anhydride and 4-Methyl-1-pentene. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30181456 | PubMed |
| 29973605 | Processing and Structure of the Lantibiotic Peptide Nso From the Human Gut Bacterium Blautia obeum A2-162 analysed by Mass Spectrometry. | Sci Rep | 2018 | https://conductscience.org/library/papers/29973605 | PubMed |
| 29628998 | Role of Streptococcus mutans surface proteins for biofilm formation. | Jpn Dent Sci Rev | 2018 | https://conductscience.org/library/papers/29628998 | PubMed |
| 28984235 | Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology. | Microbiol Spectr | 2017 | https://conductscience.org/library/papers/28984235 | PubMed |
| 28857034 | Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract. | Microbiology (Reading) | 2017 | https://conductscience.org/library/papers/28857034 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7601145
GET https://conductscience.org/api/papers/v1/7601145/cited_by?page=2